haloperidol and dihydrotetrabenazine

haloperidol has been researched along with dihydrotetrabenazine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Costentin, J; Leroux-Nicollet, I; Naudon, L	1
Rehavi, M; Roz, N; Weizman, A	1

Other Studies

2 other study(ies) available for haloperidol and dihydrotetrabenazine

Article	Year
Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra. Neuroscience letters, 1994, May-23, Volume: 173, Issue:1-2 Topics: Animals; Autoradiography; Axonal Transport; Bromocriptine; Colchicine; Dopamine; Glycoproteins; Haloperidol; Male; Medial Forebrain Bundle; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Neuropeptides; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Substantia Nigra; Synaptic Vesicles; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins	1994
Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:3 Topics: Animals; Antipsychotic Agents; Binding Sites; Biological Transport; Brain; Brain Chemistry; Clozapine; Drug Administration Schedule; Fluoxetine; Haloperidol; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Paroxetine; Piperazines; Rats; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2002

Article

Year

Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra.

Neuroscience letters, 1994, May-23, Volume: 173, Issue:1-2

Topics: Animals; Autoradiography; Axonal Transport; Bromocriptine; Colchicine; Dopamine; Glycoproteins; Haloperidol; Male; Medial Forebrain Bundle; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Neuropeptides; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Substantia Nigra; Synaptic Vesicles; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins

1994

Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:3

Topics: Animals; Antipsychotic Agents; Binding Sites; Biological Transport; Brain; Brain Chemistry; Clozapine; Drug Administration Schedule; Fluoxetine; Haloperidol; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Paroxetine; Piperazines; Rats; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2002